Filing Details
- Accession Number:
- 0001209191-20-065165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 16:06:22
- Reporting Period:
- 2020-12-23
- Accepted Time:
- 2020-12-28 16:06:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1614740 | Christopher Peetz | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-23 | 3,000 | $18.76 | 199,570 | No | 4 | P | Indirect | By The Peetz Family Trust |
Common Stock | Acquisiton | 2020-12-23 | 2,000 | $18.60 | 201,570 | No | 4 | P | Indirect | By The Peetz Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By The Peetz Family Trust |
No | 4 | P | Indirect | By The Peetz Family Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,371 | Direct |